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ABSTRACT
Objective The present cross- sectional study investigated 
quality of life (QOL) in a large cohort of German adults 
with congenital heart disease (ACHDs) in association with 
patient- related and clinical variables.
Design Cross- sectional survey.
Participants Between 2016 and 2019, a representative 
sample of 4014 adults with various forms of congenital 
heart defect (CHD) was retrospectively analysed. Inclusion 
criteria were confirmed diagnosis of CHD; participant aged 
18 years and older; and necessary physical, cognitive and 
language capabilities to complete self- report questionnaires.
Primary and secondary outcome measures QOL was 
assessed using the 5- level EQ- 5D version (EQ- 5D- 5L). 
Sociodemographic and medical information was obtained 
by a self- devised questionnaire. Associations of QOL with 
patient- reported clinical and sociodemographic variables 
were quantified using multiple regression analysis and 
multiple ordinal logit models.
Results Overall, ACHDs (41.8±17.2 years, 46.5% female) 
reported a good QOL comparable to German population 
norms. The most frequently reported complaints occurred in 
the dimensions pain/discomfort (mean: 16.3, SD: p<0.001) 
and anxiety/depression (mean: 14.3, p<0.001). QOL 
differed significantly within ACHD subgroups, with patients 
affected by pretricuspid shunt lesions indicating the most 
significant impairments (p<0.001). Older age, female sex, 
medication intake and the presence of comorbidities were 
associated with significant reductions in QOL (p<0.001). 
CHD severity was positively associated with QOL within the 
dimensions of self- care (OR 0.148, 95% CI 0.04 to 0.58) 
and mobility (OR 0.384, 95% CI 0.19 to 0.76).
Conclusion Current findings temper widely held 
assumptions among clinicians and confirm that ACHDs 
experience a generally good QOL. However, specific 
subgroups may require additional support to cope with 
disease- related challenges. The negative correlation of 
QOL with age is especially alarming as the population of 
ACHDs is expected to grow older in the future.
Trial registration number DRKS00017699; Results.
INTRODUCTION
Congenital heart defects (CHDs) are 
the most common isolated inborn organ 
malformations and affect 1.35–1.5 million 
children each year. Although 90% of patients 
with CHD survive into adulthood, many of 
them are not cured and need to adapt to their 
chronic medical condition throughout their 
lives.1 Besides symptoms related to their heart 
disease, lifelong psychosocial impairments 
may seriously impact the patients’ perceived 
quality of life (QOL).2 While clinical research 
traditionally focused on objective medical 
outcomes, the relevance of QOL and various 
related patient- reported outcomes is increas-
ingly recognised in the evaluation of care 
for adults with congenital heart disease 
(ACHDs).3
Research on QOL in ACHDs is still rela-
tively scarce and not conclusive. Empirical 
findings indicate that QOL among ACHDs 
is compromised by sociodemographic factors 
(unemployment, older age and single status), 
psychological features (negative illness 
perceptions and distressed personality) and 
Strenghts and limitations of this study
 ► First study of its kind exploring quality of life (QOL) 
among 4014 patients with different medical and 
patient- related backgrounds.
 ► Uniform conceptualisation of QOL based on EQ- 
5D- 5L, which is a highly reliable and valid outcome 
measure within the cardiovascular area.
 ► Present findings help clinicians to identify specific 
subsets of patients who require extra psychological 
support and therefore constitute a major step in pav-
ing the way towards integrative cardiac care.
 ► Causal inferences are not possible due to the cross- 
sectional design of this study.
 ► Ambiguous findings open new avenues for future 
research in understanding the construction of self- 
rated health despite or as a consequence of congen-
ital heart defect.
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medical characteristics (eg, hospitalisation and worse 
functional status). QOL has been found to be positively 
associated with higher socioeconomic and educational 
status, stronger social support, better functional class, 
better knowledge of CHD, stronger sense of coherence, 
as well as the absence of cardiac surgery. Existing findings 
are inconsistent regarding cardiovascular status, medica-
tion, age and gender, although these variables appeared 
to be the most frequently investigated determinants.4
These inconsistent results of existing research on QOL 
in ACHDs can be attributed to a lack of a clear concep-
tual background, inconsistent methods and insufficient 
sample sizes.4 Additionally, the high heterogeneity of 
ACHDs constitutes a substantial confounding factor due 
to their great anatomical and clinical disease complexity. 
Most studies on QOL in ACHDs focused on specific 
subgroups of patients, which limits their informational 
value. Consequently, clinical parameters were not suffi-
ciently examined to explain potential differences in QOL 
by the underlying diagnosis or severity of CHD. Although 
a recent review attests temporal qualitative improvements 
in QOL studies over the past decades, the current research 
situation still fails to meet scientific quality criteria.5
The present study aimed to assess QOL within a large 
sample of ACHDs in Germany and to examine poten-
tial determinants of QOL in terms of patient- related 
and medical characteristics. Identifying determinants of 
QOL, along with special needs of ACHDs, could advance 




The present study represents a subanalysis of the nation-
wide VEMAH initiative (Versorgungssituation von 
Erwachsenen mit angeborenen Herzfehlern, ‘Medical 
Care Situation of ACHD’ in English). Detailed informa-
tion on the rationale, design and methods is documented 
in a former published paper.6 VEMAH is a multicentre, 
cross- sectional study to assess the healthcare situation 
of ACHDs in Germany. Coordination of VEMAH was 
initiated and carried out by the German Heart Centre 
Munich.
Population
A questionnaire package was consecutively addressed 
to ACHDs presenting at the Department of Congenital 
Heart Disease and Paediatric Cardiology of the German 
Heart Centre Munich and the Department of Cardiology 
of the University of Erlangen. Additionally, the health 
insurance provider AOK Bayern distributed question-
naires to their policyholders with CHD in Bavaria, and the 
National Register for Congenital Heart Defects in Berlin, 
Germany, invited its members to participate in the study 
online. Guidelines on good clinical practice and data 
protection guidelines were followed. Inclusion criteria 
were (1) confirmed diagnosis of CHD according to the 
definition of Thiene and Frescura7; (2) participant age 
of 18 years and older; and (3) necessary physical, cogni-
tive and language capabilities to complete self- report 
questionnaires.
Measures
Patients completed a questionnaire either in person, online 
or by mail. Data collection took place between 2016 and 
2019. QOL was measured using the generic questionnaire 
5- level EQ- 5D version (EQ- 5D- 5L).8
Demographic and clinical information
Sociodemographic and medical information was obtained 
by a self- devised questionnaire. Medical variables included 
leading CHD, medication, presence of cyanosis, (non- )
cardiac comorbidities and hereditary diseases. Following 
the recommendations of the American College of Cardi-
ology, patients were divided into three severity groups 
based on their CHD diagnosis.9
QOL (EQ-5D-5L)
QOL was measured using the updated five- level version 
of the EQ- 5D,8 which provides a simple, generic measure 
of a patient’s perceived health status. The EQ- 5D- 5L 
consists of a descriptive system questionnaire and a 
Visual Analogue Scale (VAS). The descriptive system 
compromises five dimensions: mobility, self- care, usual 
activities, pain/discomfort and anxiety/depression. Each 
patient was asked to indicate his perceived impairments 
on a 5- point Likert scale ranging from ‘no problems’ to 
‘extreme problems/unable’. Responses were converted 
into a single weighted index score (EQ- 5D Index), which 
indicates how good or poor the respondent’s health 
status is based on existing population norms. A value set 
for the EQ- 5D- 5L, based on a representative sample of 
the German population, has recently been developed.10 
The VAS indicates a patient’s overall health state on the 
day of the questionnaire completion. It is a scale which 
ranges from 0 (‘the worst health you can imagine’) to 
100 (‘the best health you can imagine’) and provides a 
quantitative measure of a patient’s perceived health. The 
EQ- 5D- 5L proved to be a reliable and valid method for 
measuring QOL in cardiovascular populations (Cron-
bach’s alpha=0.856).11
Statistical analysis
Statistical analysis was performed using IBM SPSS 
Statistics V.24.0. Descriptive measures were calculated 
for sample characteristics, including patient- reported 
sociodemographic and medical variables (absolute and 
relative frequencies, mean and SD). The relationships 
between CHD diagnosis groups and EQ- 5D- index values, 
including the underlying dimensions mobility, self- care, 
usual activities, pain/discomfort and anxiety/depression 
were analysed. The comparison of ordinally scaled values 
was based on cumulative frequencies representing the 
relative proportion of patients with moderate to severe 
symptoms on the specific dimensions. Kruskal- Wallis tests 
were applied to reveal significant differences between 
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EQ- 5D- dimensions and metric index values. Further-
more, the relationship between EQ- 5D VAS scores and 
dedicated index values was analysed with respect to 
various patient characteristics. Multiple regression 
models using ordinary least squares (OLS) estimates 
were calculated, while bivariate Pearson coefficients were 
used to analyse the correlation between VAS and index 
scores. Finally, multiple ordinal logit models were applied 
to identify significant predictors of the respective QOL 
dimensions. For all tests, the statistical significance level 
was set at a p value of <0.05. Data analysis was currently 
performed for complete cases on each variable. To rule 
out a potential distortion of findings, a further compar-
ison between statistically included and excluded patients 
was conducted and revealed no significant differences 
concerning their QOL.
Patient and public involvement
Neither patients nor the public were involved in the design 
and conduct of this research. The methodology of this 
research was adapted in multidisciplinary collaboration.
RESULTS
Sample characteristics
A total of 4014 patients was analysed (46.5% female) 
(table 1). The mean age of ACHDs was 41.8±17.2 (18–97) 
years. Patients were subclassified according to the under-
lying CHD into six main groups, consisting of complex 
CHD (n=581), pretricuspid shunts (n=621), post- tricuspid 
shunts (n=406), right heart or pulmonary artery anoma-
lies (n=526), left heart or aortic anomalies (n=898) and 
miscellaneous CHD (n=602). Overall, 15.4% of patients 
(n=602) presented with cyanosis. The severity of CHD was 
determined according to the Warnes classification system 
as simple (n=1722, 62.0%), intermediate (n=650, 23.4%) 
or severe (n=406, 14.6%).12
QOL and ACHDs
EQ- 5D dimensions were found to be differently associated 
with CHD subgroups. Significant differences between 
the underlying diagnosis were found on all dimensions 
(p<0.001). Compared with all other subgroups, pretri-
cuspid shunts were particularly impaired in mobility, 
daily activities, pain/discomfort and anxiety/depres-
sion (table 2). In contrast, complex CHD showed the 
least problems on the respective descriptive dimensions 
(figures 1–5).
Similar results were reflected by EQ- 5D VAS and index 
values (p<0.001) with EQ- 5D VAS values being highest in 
patients with right heart/pulmonary artery anomalies and 
complex CHD and lowest in patients with pretricuspid 
shunts. Observed differences were less extreme between 
descriptive EQ- 5D Index values. Both EQ- 5D values were 
positively correlated (r=0.623, p<0.001), with coefficients 
being the lowest for patients with complex CHD (r=0.579, 
p<0.001) and highest for patients with left heart/aortic 
anomalies (r=0.653, p<0.001). Variations in QOL were 
observed, depending on the type of measurement which 
was applied. Accordingly, the mean VAS score displayed 
a significantly lower QOL than the descriptive EQ- 5D 
Index value.
Patient-related determinants of QOL
OLS regression models were applied to analyse relation-
ships of sociodemographic variables with EQ- 5D VAS 
and index values (table 3). At the 5% level of signif-
icance, age had the highest negative impact on VAS 
values (β=−0.32) and index values (β=−0.22). Thus, 
QOL decreased with advancing age. Patients aged 65+ 
years indicated the lowest values on both scales. Means 
for both EQ values were slightly higher in male patients 
than in female patients. Medication intake had significant 
negative effects on QOL in both measures. Model fit was 
slightly higher for the dependent variable in VAS values 
(R²=0.190) than EQ- 5D Index values (R²=0.112).
CHD-related determinants of QOL
EQ- 5D- dimensions were analysed more specifically in 
regard to different medical features such as connective 
Table 1 Characteristics of the underlying study population
Variables n (%)
Age group (years) (n=3903)
  18–34 1663 (42.6)
  35–64 1733 (44.4)
  65+ 507 (13.0)
Gender (n=3898)
  Male 2087 (53.5)
  Female 1811 (46.5)
Residence (n=3855)
  City 775 (20.1)
  Town 590 (15.3)
  Rural 2490 (64.6)
Insurance (n=3905)
  Public 3679 (94.2)
  Private 219 (5.6)
  No insurance 7 (.2)
Type of congenital heart defect (CHD) (n=4014)
  Complex congenital heart defects 581 (14.5)
  Primary pretricuspid shunts 621 (15.5)
  Primary post- tricuspid shunts 406 (10.1)
  Right heart/pulmonary artery anomalies 526 (13.1)
  Left heart/aortic anomalies 898 (22.4)
  Miscellaneous CHD 602 (15.0)
  Unclassifiable 380 (9.5)
Warnes class (n=2778)
  Simple 1722 (62.0)
  Moderate 650 (23.4)
  Severe 406 (14.6)
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tissue diseases with cardiovascular involvement, cyanotic 
status and severity codes of CHD. Several ordered logistic 
regression models were applied using each of the five 
dimensions as dependent variables (table 4). Generally, 
patients with comorbidities had significantly increased 
odds of reporting problems on all dimensions than 
patients without comorbidities (p<0.05). Non- cardiac 
comorbidities accounted for significantly higher odds 
of having problems than cardiac comorbidities. No 
significant effects could be observed for cyanotic status. 
Furthermore, regression models showed no effects 
for patients with simple or moderate disease severity 
classes. Apparently, severely classified patients indicated 
decreased odds of suffering from issues related to mobility 
or self- care than patients in lower Warnes’ classes.
DISCUSSION
QOL is one of the most important measures used to assess 
the psychosocial impact of chronic disease on a patient’s 
life. This is the first study to investigate patient- reported 
QOL within a cohort of 4014 patients encompassing a 
broad spectrum of CHD. QOL in ACHDs was assessed by 
using the EQ- 5D- 5L, a highly reliable and valid outcome 
measure within the cardiovascular area.13 It compromises 















anomalies Unclassifiable Miscellaneous P value
Dimension N=4014 n=581 n=621 n=406 n=526 n=898 n=380 n=602
Mobility 12.2 8.6 13.6 10.4 9.6 10.5 15.0 16.6 <0.001*
  Self- care 3.5 2.0 3.0 2.3 3.2 3.5 4.4 5.4 0.017*
  Usual activities 13.2 13.7 13.5 11.2 12.6 11.1 14.1 16.8 <0.001*
  Pain/
discomfort
16.3 13.7 20.4 12.3 11.8 14.3 19.5 22.7 <0.001*
  Anxiety/
depression
14.3 14.8 17.5 14.2 12.6 12.0 14.4 15.5 0.002*
EQ- 5D VAS n=3761 n=540 n=605 n=388 n=485 n=844 n=351 n=548 <0.001*
  Mean 76.15 78.21 73.29 77.28 79.50 77.36 74.32 72.80
  SD 18.97 17.12 19.93 19.90 17.48 18.55 19.56 19.57
EQ- 5D Index n=3690 n=540 n=583 n=383 n=489 n=828 n=344 n=523 <0.001*
  Mean 0.90 0.92 0.89 0.91 0.92 0.91 0.88 0.87
  SD 0.15 0.14 0.15 0.14 0.15 0.14 0.16 0.18
Data for EQ- 5D- dimensions represent relative percentages of patients, who indicated moderate to severe problems with respect to each dimension. Significant differences were 
calculated using Kruskal- Wallis tests for independent samples.
*P<0.05.
CHD, congenital heart defect; VAS, Visual Analogue Scale.
Figure 1 Distribution of scores for mobility. CHD, congenital 
heart defect.
Figure 2 Distribution of scores for self- care. CHD, 
congenital heart defect.
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two types of measurement and therefore provides a 
global view on QOL in terms of general life satisfaction. 
This allowed to revelation of genuine differences in 
QOL among patients with different medical and socio-
demographic backgrounds, regardless of methodological 
considerations. Within the context of this study, QOL 
quantifies the influence of CHD on a patient’s ability to 
function and derive personal satisfaction from life.
QOL in ACHDs
In line with previous findings,14 ACHDs in general 
reported a good level of well- being which is comparable 
to German population norms.15 The twofold measure 
of QOL revealed that the type of measurement affects 
QOL scores differently. Apparently, the overall VAS score 
indicated a significantly lower QOL than the descriptive 
EQ- 5D Index value. One explanation for this discrepancy 
is differences in the QOL coverage of both measures. It 
can be assumed that the descriptive system encourages a 
patient to examine QOL from various angles as the system 
breaks down QOL into various components. Thus, QOL 
is regarded as a subjective concept being influenced by 
multiple causal factors.16 In contrast, VAS picks up a one- 
dimensional view of perceived health where patients may 
indicate a higher occurrence of problems by focusing on 
somatic health restrictions imposed by their CHD. When 
comparing the quantitative association of CHD with 
QOL to other chronic disorders, the average reduction 
in VAS values in the current sample roughly resembles 
observations of various other heart diseases.15 In line 
with previous research, patients most frequently reported 
problems in the areas of pain/discomfort (16.3%) and 
anxiety/depression (14.3%).17 These rates lie consider-
ably above German population standards, which docu-
ment symptoms of anxiety/depression in 4.7% of the 
general public. This result further supports previous 
research showing that ACHDs are specifically prone to 
increased psychological distress and therefore require 
additional psychosocial support.18
A closer look at different diagnosis groups reveals 
that patients with pretricuspid shunts were particularly 
impaired in QOL. Comparable data have previously 
documented that QOL is not necessarily congruent with 
the complexity or severity of a heart disease. Even mild 
primary pretricuspid shunts can have a considerable nega-
tive impact on QOL.19 Clinical reality shows that pretri-
cuspid shunts are often detected incidentally and later in 
life creating a different psychological situation than diag-
nosis of CHD early in life. Children who grew up with 
the awareness of their CHD may acquire a greater sense 
of appreciation for life and expectations consistent with 
their capabilities and limitations.20 Qualitative research 
on ACHD indicates that patients perceive the awareness 
of their childhood condition as a ressource to re- eval-
uate life priorities and develop a new life perspective.21 A 
Figure 3 Distribution of scores for usual activities. CHD, 
congenital heart defect.
Figure 4 Distribution of scores for pain/discomfort. CHD, 
congenital heart defect.
Figure 5 Distribution of scores for anxiety/depression. CHD, 
congenital heart defect.
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recent study has further established that sense of coher-
ence is a highly significant predictor of QOL in ACHD.22 
Based on theoretical considerations, Sense of Coherence 
(SOC) develops during childhood and is thought to be 
fully developed by the age of 30 years.23 Patients who may 
be diagnosed later in life may have missed the chance to 
develop and refine coping mechanisms and may there-
fore experience the effects of their CHD more negatively 
Table 3 Patient characteristics and their correspondence with EQ- 5D vas and index values
Variables
EQ- 5D VAS EQ- 5D Index
Mean SD ß p Mean SD ß p
Age group −0.32 <0.001* −0.22 <0.001*
  18–34 83.46 14.75 0.94 0.11
  35–64 73.44 18.99 0.89 0.15
  65+ 62.23 20.83 0.82 0.21
Sex 0.01 <0.001* 0.04 0.004
  Female 76.11 19.07 0.90 0.15
  Male 76.55 18.85 0.91 0.14
Residence 0.02 0.084 0.03 0.060
  City 76.30 17.49 0.90 0.15
  Town 77.08 18.26 0.90 0.15
  Rural 76.01 19.46 0.90 0.15
Medication −0.22 <0.001* −0.19 <0.001*
  No 79.16 17.13 0.92 0.13
  Yes 65.17 20.69 0.83 0.20
Multivariate analysis was performed using ordinary least squares regression models with EQ- 5D VAS and index values as dependent 
variables.
*P<0.05.
VAS, Visual Analogue Scale.














  Cardiac cmorbidities 1463 0.302* (0.25 to 0.36) 0.525* (0.38 to 
0.73)
0.348* (0.29 to 
0.41)
0.331* (0.28 to 0.39) 0.467* (0.40 
to 0.54)
  Non- cardiac 
comorbidities
819 0.263* (0.22 to 0.32) 0.281* (0.20 to 
0.39)
0.222* (0.18 to 
0.27)
0.311* (0.26 to 0.37) 0.243* (0.20 
to 0.29)
Cyanosis
  Cyanotic 744 0.904 (0.49 to 1.68) 0.396 (0.12 to 
1.26)
0.880 (0.50 to 
1.56)
1.088 (0.65 to 1.82) 0.850 (0.51 to 
1.41)
  Acyanotic 2176 1.452 (0.70 to 3.02) 0.774 (0.20 to 
3.04)
1.207 (0.63 to 
2.30)
1.011 (0.58 to 1.77) 0.695 (0.40 to 
1.19)
Warnes class
  Simple 1722 1.396 (0.69 to 2.84) 0.707 (0.18 to 
2.84)
1.109 (0.60 to 
2.06)
0.984 (0.57 to 1.69) 0.739 (0.44 to 
1.24)
  Moderate 650 0.848 (0.50 to 1.45) 0.538 (0.17 to 
1.69)
0.985 (0.60 to 
1.61)
0.884 (0.57 to 1.37) 0.921 (0.60 to 
1.41)








Displayed are ORs and upper and lower bounds (95% CI), respectively, which were obtained from several ordered logistic regressions 
using EQ dimensions as dependent variable.
*P<0.05.
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leading to higher emotional distress. Life- stage variables, 
such as age at diagnosis or years of survival, need to be 
further investigated as possible determinants of QOL.
Socioeconomic determinants of QOL
Despite good overall QOL, EQ- 5D Index and VAS values 
deteriorated with increasing age. This might be explained 
by the uncertainty in disease prognosis manifesting itself 
in an increased sense of vulnerability in this patient 
group.24 Most patients with CHD are known to do well 
in the first decades of life until they eventually develop 
unexpected age and disease- related comorbidities. This 
development deserves special attention as the group of 
ACHD is expected to grow steadily in the future.1
In contrast to previous findings,14 the present study 
revealed modest gender- related differences in QOL. 
Women were more likely to report poor QOL than men. 
These findings may be attributed to psychosocial factors 
rather than gender per se.25 In general, gender is found 
to influence health expectations, health behaviours and 
perceived health outcomes.26 Women may face a triple 
burden shouldering family responsibility, professional 
ambition and demands of their chronic disease. Research 
has demonstrated that women were less likely to return 
to work, more likely to recline psychological counsel-
ling and more socially isolated than men.27 It has also 
been argued that women were more willing to disclose 
problems than men concerning their QOL, which may 
partly explain the difference in their QOL.26 Engelfriet 
et al also showed that women with CHD were more often 
symptomatic and presented functional impairments, 
despite a higher overall mortality in men over a 5- year 
period.28 Gender disparities in patient–provider commu-
nication and dissatisfaction with healthcare might be 
another reason for decreased QOL in women. They 
might have higher expectations and a stronger demand 
for more participatory encounters with their healthcare 
providers.25 Improved recognition and understanding of 
these gender- specific differences and challenges among 
ACHDs is vital to improve their cardiovascular health 
over the long term.
Reported medication intake was inversely associated 
with QOL in the present study. This appears plausible 
because extensive or inappropriate medication can lead 
to severe side effects and even higher morbidity, which 
may considerably impair QOL.29 Aside from incorrect 
pharmaceutical treatment, the daily intake of medication 
is a constant reminder of illness and may have a negative 
impact on life satisfaction. Consequently, medication may 
be either a facilitator by providing new opportunities or 
an intensifier of problems by adverse psychological and 
somatic side effects.
Clinical determinants of QOL
Despite all advances in cardiac care, many patients with 
CHD are left with significant residua, sequels or compli-
cations from the underlying anomaly.9 30 The impact of 
comorbidities in ACHD is largely underestimated.31 The 
current study indicates that the presence of comorbidi-
ties increases the risk of problems on all dimensions of 
the EQ- 5D. It is conceivable that affected patients report 
a lower health status since they may experience serious 
restrictions in various life domains. As comorbidities 
become increasingly dominant with advancing age, they 
may also explain the recorded deterioration of QOL with 
age in the present sample.
It is remarkable that patients with a more complex 
CHD scored significantly better in QOL domains. Until 
now, research has failed to demonstrate a clear- cut 
correlation between disease complexity and QOL.4 
Although the present finding may seem counterintui-
tive at first, there are various possible explanations for a 
better QOL in the light of a chronic condition. Keyes’ 
two- continua model of mental health32 provides an 
important framework for explaining why patients might 
experience a good QOL despite their CHD. Accord-
ingly, mental health is a complex state resulting from 
an interplay of environmental and psychological factors 
that have a profound influence on one’s subjective well- 
being. Keyes’ model holds that mental health (sometimes 
referred to as mental well- being) and mental illness are 
orthogonally related phenomena and not two endpoints 
of a single continuum. Although the current state of 
research confirms elevated levels of mental illness among 
ACHDs,18 this does not necessarily imply impaired mental 
well- being or decreased QOL among these patients. 
Furthermore, the disability paradox explains why individ-
uals may perceive a high QOL despite serious limitations. 
Accordingly, QOL depends on finding a balance in life 
and maintaining harmonious social relationships.33 The 
characteristics associated with a severe CHD may poten-
tially include favourable and compromising factors and 
thus explain both extremes of QOL in ACHDs. Lastly, 
growing up with a CHD can lead to a so- called ‘response 
shift’ in terms of redefining priorities in one’s life.34 It 
is perceivable that patients develop values different from 
those of healthy persons in the face of a life- threatening, 
chronic illness. In this context, Sprangers and Schwartz35 
proposed a theoretical model to clarify and predict 
changes in QOL as a result of various dispositional char-
acteristics, a patient’s health status and mechanisms to 
accommodate to these changes.35
Despite the extensive power of the present study, 
current results should be interpreted with caution due to 
certain limitations. The study was retrospective and cross- 
sectional in nature and does not allow disentanglement 
of any conclusions about the directionality of effects or 
the development of QOL over time. Since all information 
was based on patient- reported outcomes, medical data 
may have been classified incorrectly due to a patient’s 
limited knowledge of his or her condition. Consequently, 
surgical status of patients could not be identified. Subse-
quently, it would be advisable to synchronise these data 
with medical records in order to disentangle the effects 
of empirical–medical observations on QOL. As the 
enrolment was voluntary, selection bias could not be 
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excluded and may hamper representativeness. Further, 
this study was performed at a tertiary care centre for 
ACHD, which does not reflect the typical population of 
CHD. Further doubts must be raised about whether the 
applied EQ- 5D- 5L provides an accurate tool to evaluate 
QOL among AHCDs. Although the updated 5L version 
demonstrates superior performance compared with its 
predecessor, psychometric properties in terms of high 
ceiling effects and weak discriminatory power have previ-
ously been questioned.36 It has further been shown that 
the choice of value set has an impact on EQ- 5D scores.37 
Since the present study used a population- based value 
set to construct QOL estimates, we strongly encourage to 
re- evaluate current findings on the basis of experience- 
based value sets. Further, the inventory was adminis-
tered in three different ways. However, measurement 
invariance across the survey methods was not tested, 
and the equivalence across the survey methods remains 
questionable. Since the primary aim of this study was to 
assess clinical determinants of QOL, sociodemographic 
variables were not explicitly reviewed within the present 
analysis. Based on the German healthcare system, the 
depicted sociodemographic variables are crucial indi-
cators of access to medical supply and were therefore 
separately analysed. Given previously documented asso-
ciations between sociodemographic factors and QOL, 
generalisation of the conclusions and transmission to 
patients from differing socioeconomic conditions are 
debatable. The present survey assessed biological sex 
with a binary value. Given the increasing incidence of 
transgender and gender non- binary individuals and that 
large health disparities exist for this population,38 future 
research should increasingly expand measures of sex/
gender to be trans- inclusive. Finally, no control group 
was involved, and data could only be compared with 
published national EQ- 5D studies.
CONCLUSION
The present study shows that ACHD experience—on 
aggregate—a good QOL which is indistinguishable from 
healthy individuals. Against expectation, patients with 
complex CHD scored higher on QOL. However, specific 
subgroups of patients indicate significant reductions in 
QOL and may require extra support in their care to cope 
with challenges associated with their underlying CHD. 
The negative correlation with age deserves particular 
attention as it could lead to a decrease in QOL with the 
growing median age of this patient population.
QOL is regarded as a central target in the treatment of 
chronically ill patients. This study supports the need to 
further assess and promote mental well- being in ACHDs 
to safeguard surgical successes of the past decades which 
have ensured the survival of patients with CHD into adult-
hood. Successful treatment implies not only an increased 
length of survival but also enhanced subjective well- being 
and QOL.
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